MAVERICK-HCM: Phase 2 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Concentration-Guided Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
Publication
, Conference
Heitner, S; Wang, A; Jacoby, D; Lester, S; Carlson, T; Zhang, D; Sehnert, A; Ho, C
Published in: CIRCULATION
2018
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
2018
Volume
138
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Heitner, S., Wang, A., Jacoby, D., Lester, S., Carlson, T., Zhang, D., … Ho, C. (2018). MAVERICK-HCM: Phase 2 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Concentration-Guided Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy. In CIRCULATION (Vol. 138).
Heitner, Stephen, Andrew Wang, Daniel Jacoby, Steven Lester, Timothy Carlson, David Zhang, Amy Sehnert, and Carolyn Ho. “MAVERICK-HCM: Phase 2 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Concentration-Guided Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy.” In CIRCULATION, Vol. 138, 2018.
Heitner S, Wang A, Jacoby D, Lester S, Carlson T, Zhang D, et al. MAVERICK-HCM: Phase 2 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Concentration-Guided Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy. In: CIRCULATION. 2018.
Heitner, Stephen, et al. “MAVERICK-HCM: Phase 2 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Concentration-Guided Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy.” CIRCULATION, vol. 138, 2018.
Heitner S, Wang A, Jacoby D, Lester S, Carlson T, Zhang D, Sehnert A, Ho C. MAVERICK-HCM: Phase 2 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Concentration-Guided Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy. CIRCULATION. 2018.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
2018
Volume
138
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology